I. Mellman

Immunology · 2000–2023

A researcher in the Science corpus: 18 papers; trusts 15 researchers and is trusted by 23 researchers here, as inferred from the citation graph.

Subfields

Immunology — 281 citations into it; #152 of 2,160 by trust here, #57 by citations
Oncology — 222 citations into it; #304 of 1,698 by trust here, #75 by citations
Biological Psychiatry — 6 citations into it

Whom I. Mellman trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

Who trusts I. Mellman overall

Papers from I. Mellman's perspective

Ordered by how strongly the researchers I. Mellman trusts endorse each paper. Same corpus, a different order for every researcher.

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome (Science)
Cancer immunoediting: from immunosurveillance to tumor escape (Nature Immunology)
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer (New England Journal of Medicine)
The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma (New England Journal of Medicine)
The B7 family revisited. (Annual Review of Immunology)
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms (Molecular and Cellular Biology)
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine (Proceedings of the National Academy of Sciences of the United States of America)
Ido expression by dendritic cells: tolerance and tryptophan catabolism (Nature reviews. Immunology)
SHP-1 and SHP-2 Associate with Immunoreceptor Tyrosine-Based Switch Motif of Programmed Death 1 upon Primary Human T Cell Stimulation, but Only Receptor Ligation Prevents T Cell Activation1 (Journal of Immunology)

Their papers

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing (2014) — 1,155 citations
MAP Kinase Inhibition Promotes T Cell and Anti-tumor Activity in Combination with PD-L1 Checkpoint Blockade. (2016) — 654 citations
Cell biology of antigen processing in vitro and in vivo. (2005) — 1,215 citations
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research (2009) — 1,349 citations
Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer (2023) — 1,108 citations
Peripheral T cell expansion predicts tumour infiltration and clinical response (2020) — 630 citations
TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells (2018) — 4,528 citations
Elements of cancer immunity and the cancer–immune set point (2017) — 4,557 citations
T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition (2016) — 1,468 citations
Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients (2014) — 4,940 citations
Oncology meets immunology: the cancer-immunity cycle. (2013) — 6,077 citations
Cancer immunotherapy comes of age (2011) — 3,898 citations
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide (2007) — 1,876 citations
Differential Lysosomal Proteolysis in Antigen-Presenting Cells Determines Antigen Fate (2005) — 782 citations
Matters Arising Quantitative and Dynamic Assessment of the Contribution of the ER to Phagosome Formation (2005) — 290 citations
Activation of Lysosomal Function During Dendritic Cell Maturation (2003) — 754 citations
Dendritic cells: specialized and regulated antigen processing machines. (2001) — 2,484 citations
The Induction of Tolerance by Dendritic Cells That Have Captured Apoptotic Cells (2000) — 1,333 citations